The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection
暂无分享,去创建一个
[1] J. Levy,et al. Several CD4 domains can play a role in human immunodeficiency virus infection in cells , 1991, Journal of virology.
[2] C. Kuiken,et al. Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution. , 1991, Virology.
[3] P. A. Peterson,et al. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance , 1985, Cell.
[4] S. Harrison,et al. Human immunodeficiency virus gp120 binding C'C" ridge of CD4 domain 1 is also involved in interaction with class II major histocompatibility complex molecules. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Martin,et al. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes , 1992, Journal of virology.
[6] W. Jefferies,et al. Peptide and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a structure with four immunoglobulin-related domains. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. Compans,et al. The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing. , 1990, Virology.
[8] M. Essex,et al. The N-terminal region of the human immunodeficiency virus envelope glycoprotein gp120 contains potential binding sites for CD4. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[9] L. Lopalco,et al. Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins? , 1992, AIDS research and human retroviruses.
[10] D. Schomburg,et al. Synthesis and characterization of the hydrophilic C-terminal domain of the human immunodeficiency virus type 1-encoded virus protein U (Vpu). , 1993, Peptide research.
[11] J. Pound,et al. Modulation of MHC antigen expression by viruses and oncogenes , 1991, Immunology Today.
[12] M. Cloyd,et al. Interference patterns of human immunodeficiency viruses HIV-1 and HIV-2. , 1990, Virology.
[13] E. Wingender,et al. The Human Immunodeficiency Virus Type 1 Encoded Vpu Protein is Phosphorylated by Casein Kinase-2 (CK-2) at Positions Ser52 and Ser56 within a Predicted α-Helix-Turn-α-Helix-Motif , 1994 .
[14] A J Langlois,et al. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. Baltimore,et al. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[16] E. Major,et al. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes , 1994, Journal of virology.
[17] P. Anderson,et al. Biochemical identification of a direct physical interaction between the CD4: p56lck and Ti(TcR)/CD3 complexes , 1991, European journal of immunology.
[18] A. Jochemsen,et al. Adenovirus type 12 E1A down regulates expression of a transgene under control of a major histocompatibility complex class I promoter: evidence for transcriptional control , 1989, Journal of virology.
[19] R. Fagard,et al. Interaction of human immunodeficiency virus glycoprotein 160 with CD4 in Jurkat cells increases p56lck autophosphorylation and kinase activity. , 1992, International immunology.
[20] R. Klausner,et al. A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains , 1992, Cell.
[21] J. Chermann,et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.
[22] E. Reinherz,et al. Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding , 1988, Nature.
[23] Arnold J. Levine,et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.
[24] S. Luria,et al. Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. Theodore,et al. CD4 modulation of noninfected human T lymphocytes by HIV-1 envelope glycoprotein gp120: contribution to the immunosuppression seen in HIV-1 infection by induction of CD4 and CD3 unresponsiveness. , 1994, Journal of acquired immune deficiency syndromes.
[26] B. Seed,et al. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4 , 1988, Cell.
[27] C. Janeway,et al. The influence of valence on the functional activities of monoclonal anti-L3T4 antibodies. Discrimination of signaling from other effects. , 1987, Journal of immunology.
[28] E. Field,et al. Kinetics of anti-CD4-induced T helper cell depletion and inhibition of function. Activation of T cells by the CD3 pathway inhibits anti-CD4-mediated T cell elimination and down-regulation of cell surface CD4. , 1992, Journal of immunology.
[29] R. Siliciano,et al. Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: Effect of HIV sequence variation and a mechanism for CD4+ cell depletion , 1988, Cell.
[30] R. North,et al. Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter , 1991, Nature.
[31] G. Pauli,et al. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins , 1987 .
[32] Reed J. Harris,et al. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. , 1990, The Journal of biological chemistry.
[33] M. Marsh,et al. Human immunodeficiency virus infection of CD4‐bearing cells occurs by a pH‐independent mechanism. , 1988, The EMBO journal.
[34] C. Morimoto,et al. Cross-linking of T3 (CD3) with T4 (CD4) enhances the proliferation of resting T lymphocytes. , 1987, Journal of immunology.
[35] T. Mustelin,et al. Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[36] C. Rudd,et al. The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[37] W. Haseltine,et al. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[38] D. Weiner,et al. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. , 1993, AIDS research and human retroviruses.
[39] W. Hendrickson,et al. Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices. , 1994, Structure.
[40] J. Sodroski,et al. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity , 1986, Nature.
[41] M. Rosenberg,et al. The N-terminal 31 amino acids of human immunodeficiency virus type 1 envelope protein gp120 contain a potential gp41 contact site , 1991, Journal of virology.
[42] J. Gavalchin,et al. Identification of a putative cellular receptor for HTLV-I by a monoclonal antibody, Mab 34-23. , 1993, Virology.
[43] J. Marth,et al. Specific CD45 isoforms differentially regulate T cell receptor signaling. , 1994, The EMBO journal.
[44] M. Jones,et al. Phorbol esters down-regulate transcription and translation of the CD4 gene. , 1991, Journal of immunology.
[45] A. Houweling,et al. Post-transcriptional control of class I MHC mRNA expression in adenovirus 12-transformed cells. , 1987, Science.
[46] C. Melief,et al. Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity , 1983, Nature.
[47] C. Kozak. Genetic mapping of a mouse chromosomal locus required for mink cell focus-forming virus replication , 1983, Journal of virology.
[48] J. Levy,et al. Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Lenburg,et al. The cytoplasmic domain of CD4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef , 1994, Journal of virology.
[50] C. Kozak,et al. Genetic mapping of the amphotropic murine leukemia virus receptor on mouse chromosome 8. , 1994, Virology.
[51] R. Weinmann,et al. Down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells is accompanied by an increase in factor binding , 1992, Journal of virology.
[52] P. Earl,et al. Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein. , 1993, AIDS research and human retroviruses.
[53] J. Skowroński,et al. Altered T cell activation and development in transgenic mice expressing the HIV‐1 nef gene. , 1993, The EMBO journal.
[54] S. Jentsch. The ubiquitin-conjugation system. , 1992, Annual review of genetics.
[55] P. Goodfellow,et al. Human T cell leukemia viruses use a receptor determined by human chromosome 17. , 1988, Science.
[56] L. Ratner,et al. Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[57] S. Astrin,et al. Host Susceptibility to endogenous viruses: defective, glycoprotein-expressing proviruses interfere with infections , 1981, Journal of virology.
[58] J. Sodroski,et al. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies , 1994, Journal of virology.
[59] C. Cheng‐Mayer,et al. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. , 1994, Immunity.
[60] M. Newell,et al. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen , 1990, Nature.
[61] M. Wainberg,et al. Diminution of CD4 surface protein but not CD4 messenger RNA levels in monocytic cells infected by HIV-1. , 1991, AIDS.
[62] Robin A. Weiss,et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain , 1986, Cell.
[63] S. Venkatesan,et al. Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. , 1988, Science.
[64] C. Figdor,et al. Induction of phenotypic differentiation, interleukin 2 production, and PHA responsiveness of "immature" human thymocytes by interleukin 1 and phorbol ester. , 1983, Journal of immunology.
[65] J. Garcia,et al. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef , 1991, Nature.
[66] D. Stern,et al. The Ick tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain , 1989, Cell.
[67] C. Disteche,et al. Localization of a lymphocyte-specific protein tyrosine kinase gene (lck) at a site of frequent chromosomal abnormalities in human lymphomas. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[68] H. Scholz,et al. Ganglioside-induced CD4 endocytosis occurs independent of serine phosphorylation and is accompanied by dissociation of P56lck. , 1992, Journal of immunology.
[69] T. L. Collins,et al. p56lck association with CD4 is required for the interaction between CD4 and the TCR/CD3 complex and for optimal antigen stimulation. , 1992, Journal of immunology.
[70] H. Klinger,et al. Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[71] I. Jones,et al. Legitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin , 1993, Journal of virology.
[72] M. O'Donnell,et al. The transmembrane glycoprotein of human immunodeficiency virus type 1 induces syncytium formation in the absence of the receptor binding glycoprotein , 1992, Journal of virology.
[73] P. Kavathas,et al. Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the amino-terminal domain of the p56lck tyrosine protein kinase , 1990, Molecular and cellular biology.
[74] E. Freed,et al. Identification of conserved residues in the human immunodeficiency virus type 1 principal neutralizing determinant that are involved in fusion. , 1991, AIDS research and human retroviruses.
[75] C. Janeway,et al. Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells , 1983, The Journal of experimental medicine.
[76] Daniel G. Miller,et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[77] Lawrence H. Pinto,et al. Influenza virus M2 protein has ion channel activity , 1992, Cell.
[78] D. Montefiori,et al. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network. , 1993, The Journal of clinical investigation.
[79] T. L. Collins,et al. Disruption of the CD4-p56lck complex is required for rapid internalization of CD4. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[80] S. Chattopadhyay,et al. A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ectropic, amphotropic, xenotropic, and mink cell focus-forming viruses , 1984, Journal of virology.
[81] Q. Sattentau,et al. The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. , 1988, AIDS.
[82] E. Shevach,et al. Role of the L3T4-antigen in T cell activation. II. Inhibition of T cell activation by monoclonal anti-L3T4 antibodies in the absence of accessory cells. , 1985, Journal of immunology.
[83] E. Reinherz,et al. Surface structures involved in target recognition by human cytotoxic T lymphocytes. , 1982, Science.
[84] A. Fauci,et al. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.
[85] F. Maldarelli,et al. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein , 1993, Journal of virology.
[86] J. R. Weber,et al. Association of the tyrosine kinase LCK with phospholipase C-gamma 1 after stimulation of the T cell antigen receptor , 1992, The Journal of experimental medicine.
[87] G. Aldrovandi,et al. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity , 1994, Journal of virology.
[88] E. Wecker,et al. Downregulation of HLA class I antigens in HIV-1-infected cells. , 1989, AIDS research and human retroviruses.
[89] P. Goodfellow,et al. Localization of the receptor gene for type D simian retroviruses on human chromosome 19 , 1990, Journal of virology.
[90] F. Titti,et al. Homologous superinfection of both producer and nonproducer HIV-infected cells is blocked at a late retrotranscription step. , 1993, Virology.
[91] N. Besansky,et al. Unintegrated human immunodeficiency virus type 1 DNA in chronically infected cell lines is not correlated with surface CD4 expression , 1991, Journal of virology.
[92] Y Nishizuka,et al. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. , 1982, The Journal of biological chemistry.
[93] R. Weinmann,et al. Negative regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells via a retinoic acid response element , 1992, Journal of virology.
[94] M. Eiden,et al. Gibbon ape leukemia virus and the amphotropic murine leukemia virus 4070A exhibit an unusual interference pattern on E36 Chinese hamster cells , 1993, Journal of virology.
[95] M. Reitz,et al. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages , 1990, Journal of virology.
[96] M. Martin,et al. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4 , 1992, Journal of virology.
[97] C. Rudd,et al. The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[98] H. Rubin,et al. The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. I. Establishment of interference. , 1966, Virology.
[99] R. Germain,et al. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8 , 1992, Nature.
[100] R. Burgeson,et al. Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor , 1991, Journal of virology.
[101] O. Danos,et al. Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef , 1993, Journal of virology.
[102] J. McCutchan,et al. Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages , 1993, Journal of virology.
[103] B. Du,et al. Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity , 1991, Journal of virology.
[104] L. Leinwand,et al. Assignment of the receptor for ecotropic murine leukemia virus to mouse chromosome 5 , 1978, The Journal of experimental medicine.
[105] D. Richman,et al. Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells , 1990, The Journal of experimental medicine.
[106] J. Minna,et al. Mouse chromosome 5 codes for ecotropic murine leukaemia virus cell-surface receptor , 1978, Nature.
[107] A. Profy,et al. Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1 , 1990, Science.
[108] E. Engleman,et al. Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. , 1990, The Journal of biological chemistry.
[109] U. Schubert,et al. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments , 1994, Journal of virology.
[110] H. Yoshida,et al. Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV. , 1990, Journal of immunology.
[111] S. Kassis,et al. Effect of human immunodeficiency virus gp120 glycoprotein on the association of the protein tyrosine kinase p56lck with CD4 in human T lymphocytes. , 1991, The Journal of biological chemistry.
[112] R. Redfield,et al. Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[113] B. Andresen,et al. Internalization, lysosomal degradation and new synthesis of surface membrane CD4 in phorbol ester-activated T-lymphocytes and U-937 cells. , 1992, Experimental cell research.
[114] J. Sodroski,et al. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein , 1991, Journal of virology.
[115] E. Freed,et al. Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain , 1991, Journal of virology.
[116] D. Richman,et al. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene , 1994, Journal of virology.
[117] E. Tschachler,et al. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage. , 1990, Virology.
[118] B. Kemp,et al. N-terminal residues 105-117 of HIV-1 gp120 are not involved in CD4 binding. , 1991, AIDS research and human retroviruses.
[119] L. Samelson,et al. Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck , 1989, Nature.
[120] R. Ehrlich,et al. Transcriptional and posttranscriptional regulation of class I major histocompatibility complex genes following transformation with human adenoviruses , 1991, Journal of virology.
[121] D. Richman,et al. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. , 1991, The Journal of clinical investigation.
[122] F. Celada,et al. Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding , 1990, The Journal of experimental medicine.
[123] A. Fauci,et al. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. , 1988, Science.
[124] R. Lamb,et al. Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA , 1985, Journal of virology.
[125] T. Kost,et al. Human immunodeficiency virus infection and syncytium formation in HeLa cells expressing glycophospholipid-anchored CD4 , 1991, Journal of virology.
[126] E. Delwart,et al. Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference , 1989, Journal of virology.
[127] S. Herrmann,et al. HIV-gp120 can block CD4-class II MHC-mediated adhesion. , 1990, Journal of immunology.
[128] N. Abraham,et al. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck , 1991, Nature.
[129] Jonathan A. Cooper,et al. Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck) , 1988, Molecular and cellular biology.
[130] R. Edwards,et al. Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[131] G. Schiavo,et al. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients. , 1992, Journal of immunology.
[132] M. Castagna,et al. Further characterization of tumor-promoter-mediated activation of protein kinase C. , 1984, Biochemical and biophysical research communications.
[133] M. Kieny,et al. Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication , 1988, The Journal of experimental medicine.
[134] C. Cheng‐Mayer,et al. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[135] P. Kourilsky,et al. Adenovirus E1A‐mediated regulation of class I MHC expression. , 1986, The EMBO journal.
[136] L. Hood,et al. Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. , 1988, Science.
[137] K. Luo,et al. Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site , 1990, Molecular and cellular biology.
[138] R. Ricciardi,et al. Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[139] B. Fadeel,et al. V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. , 1993, Virology.
[140] S. Zolla-Pazner,et al. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1 , 1989, Journal of virology.
[141] D. Singer,et al. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. , 1993, Science.
[142] S. Zolla-Pazner,et al. Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120 , 1993, Journal of virology.
[143] J. Sambrook,et al. Expression of wild-type and mutant forms of influenza hemagglutinin: The role of folding in intracellular transport , 1986, Cell.
[144] H. Lodish,et al. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[145] K. M. Hwang,et al. Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. , 1988, Science.
[146] W. Hendrickson,et al. Mutational analysis of the interaction between CD4 and class II MHC: Class II antigens contact CD4 on a surface opposite the gp120-binding site , 1991, Cell.
[147] R. Lamb,et al. Influenza A virus M2 ion channel protein: a structure-function analysis , 1994, Journal of virology.
[148] C. Sherr,et al. Isolation from the asian mouse Mus caroli of an endogenous type C virus related to infectious primate type C viruses. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[149] Jerome A. Zack,et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.
[150] B. Du,et al. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[151] J. Strominger,et al. Structural features of the cytoplasmic region of CD4 required for internalization. , 1990, The EMBO journal.
[152] F. Maldarelli,et al. Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity , 1993, Journal of virology.
[153] H. Jörnvall,et al. 95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[154] U. Rapp,et al. Cell surface receptors for endogenous mouse type C viral glycoproteins and epidermal growth factor: tissue distribution in vivo and possible participation in specific cell-cell interaction. , 1980, Journal of supramolecular structure.
[155] P. Marrack,et al. The antigen-specific, major histocompatibility complex-restricted receptor on T cells. , 1986, Advances in immunology.
[156] N. Katunuma,et al. Tryptase TL2 in the membrane of human T4+ lymphocytes is a novel binding protein of the V3 domain of HIV‐1 envelope glycoprotein gp120 , 1991, FEBS letters.
[157] R. Swanstrom,et al. Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells , 1993, Journal of virology.
[158] Roberta,et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. , 1991, The Journal of clinical investigation.
[159] Steven J. Burakoff,et al. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[160] R. Aebersold,et al. Tyrosyl phosphorylation and activation of MAP kinases by p56lck. , 1992, Science.
[161] Y. Koyanagi,et al. Cell type-specific heterogeneity of the HIV-1 V3 loop in infected individuals: selection of virus in macrophages and plasma. , 1994, Virology.
[162] H. Temin,et al. Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus , 1980, Journal of virology.
[163] J. McCune,et al. HIV induces thymus depletion in vivo , 1993, Nature.
[164] J. Cunningham,et al. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection , 1989, Cell.
[165] Michael Emerman,et al. Single amino-acid changes in HIV envelope affect viral tropism and receptor binding , 1989, Nature.
[166] I. Macreadie,et al. Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells. , 1994, Virology.
[167] B. Crise,et al. Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum , 1992, Journal of virology.
[168] R. Aebersold,et al. Phosphorylation of serine 59 of p56lck in activated T cells. , 1993, The Journal of biological chemistry.
[169] M. Malim,et al. Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[170] J K Nicholson,et al. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. , 1986, Science.
[171] P S Sarma,et al. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. , 1973, Virology.
[172] J. Garcia,et al. Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells , 1992, Journal of virology.
[173] W. Haseltine,et al. Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export , 1992, Journal of virology.
[174] M. Stevenson,et al. Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: Mechanism for persistence in AIDS , 1988, Cell.
[175] C. Chase,et al. Bovine cells expressing bovine herpesvirus 1 (BHV-1) glycoprotein IV resist infection by BHV-1, herpes simplex virus, and pseudorabies virus , 1990, Journal of virology.
[176] G. Superti-Furga,et al. Csk inhibition of c‐Src activity requires both the SH2 and SH3 domains of Src. , 1993, The EMBO journal.
[177] C. Janeway,et al. Physical association of CD4 with the T cell receptor. , 1992, Journal of immunology.
[178] J. Levy,et al. Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles , 1990, Journal of virology.
[179] C. Janeway,et al. The biologic activity of anti-T cell receptor V region monoclonal antibodies is determined by the epitope recognized. , 1988, Journal of immunology.
[180] R. Perlmutter,et al. Interaction of the unique N-terminal region of tyrosine kinase p56 lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs , 1990, Cell.
[181] J. Grundy,et al. Down-regulation of the class I HLA heterodimer and beta 2-microglobulin on the surface of cells infected with cytomegalovirus. , 1992, The Journal of general virology.
[182] R. Arlinghaus,et al. Inhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120 , 1993, Journal of virology.
[183] A. Fields,et al. Human immunodeficiency virus induces phosphorylation of its cell surface receptor , 1988, Nature.
[184] A. Barclay,et al. Crystallization of a soluble form of the rat T-cell surface glycoprotein CD4 complexed with Fab from the W3/25 monoclonal antibody. , 1990, Journal of molecular biology.
[185] E. Reinherz,et al. Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[186] H. Varmus,et al. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor , 1993, Cell.
[187] A. Hovanessian,et al. The cytopathic effect of human immunodeficiency virus is independent of high levels of unintegrated viral DNA accumulated in response to superinfection of cells. , 1993, The Journal of general virology.
[188] J. Vlach,et al. Activation of human immunodeficiency virus type 1 provirus in T-cells and macrophages is associated with induction of inducer-specific NF-kappa B binding proteins. , 1992, Virology.
[189] C. Auffray,et al. Regulation of T helper‐B lymphocyte adhesion through CD4‐HLA class II interaction , 1990, European journal of immunology.
[190] J. Parnes,et al. Adhesion versus coreceptor function of CD4 and CD8: role of the cytoplasmic tail in coreceptor activity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[191] C. Fox,et al. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse , 1993, The Journal of experimental medicine.
[192] A. Capron,et al. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals , 1992, The Journal of experimental medicine.
[193] W. Hendrickson,et al. Molecular characteristics of recombinant human CD4 as deduced from polymorphic crystals. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[194] N. Haigwood,et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis , 1992, The Journal of experimental medicine.
[195] P. Johnson,et al. Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[196] D. Dimitrov,et al. Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time , 1993, Journal of virology.
[197] D. Pennington,et al. CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. , 1993, The EMBO journal.
[198] D. Baltimore,et al. Erratum: Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes (Proc. Natl. Acad. Sci. USA (June 1991) 88 (5011-5015)) , 1992 .
[199] J. Fujimoto,et al. Human T lymphocytes and monocytes bear the same Leu-3(T4) antigen. , 1986, Journal of immunology.
[200] J. Coffin,et al. Determinants for receptor interaction and cell killing on the avian retrovirus glycoprotein gp85 , 1986, Cell.
[201] B. Moss,et al. Expression of the HTLV-III envelope gene by a recombinant vaccinia virus , 1986, Nature.
[202] G. Nakamura,et al. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor , 1987, Cell.
[203] M. Waxham,et al. Sequence similarities between human immunodeficiency virus gp41 and paramyxovirus fusion proteins. , 1987, AIDS research and human retroviruses.
[204] N. Shastri,et al. Requirement for association of p56 lck with CD4 in antigen-specific signal transduction in T cells , 1991, Cell.
[205] J. Sodroski,et al. Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction. , 1992, Virology.
[206] T. Copeland,et al. Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. , 1985, Science.
[207] D. Volsky,et al. Restoration of cell surface CD4 expression in human immunodeficiency virus type 1-infected cells by treatment with a Tat antagonist , 1992, Journal of virology.
[208] M. Kuroda,et al. Coexistence of Fusion Receptors for Human T‐Cell Leukemia Virus Type‐I (HTLV‐I) and Human Immunodeficiency Virus Type‐1 (HIV‐1) on MOLT‐4 Cells , 1991, Microbiology and immunology.
[209] H. Gendelman,et al. Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study , 1988, Journal of virology.
[210] J. Lautenberger,et al. Heterogeneity of Nef proteins in cells infected with human immunodeficiency virus type 1. , 1990, Virology.
[211] M. Marsh,et al. Internalization and recycling of CD4 transfected into HeLa and NIH3T3 cells. , 1989, The EMBO journal.
[212] H. Rubin,et al. A VIRUS IN CHICK EMBRYOS WHICH INDUCES RESISTANCE IN VITRO TO INFECTION WITH ROUS SARCOMA VIRUS. , 1960, Proceedings of the National Academy of Sciences of the United States of America.
[213] P. Vogt,et al. Patterns of viral interference in the avian leukosis and sarcoma complex. , 1966, Virology.
[214] F. Miedema,et al. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. , 1990, The Journal of clinical investigation.
[215] M. Gonda,et al. Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. , 1985, Science.
[216] K. Raška,et al. Tumorigenicity of adenovirus-transformed rat cells and expression of class I major histocompatibility antigen. , 1984, Virology.
[217] H. Klenk,et al. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60 , 1992, Nature.
[218] N. Chirmule,et al. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. , 1993, Blood.
[219] T. Klimkait,et al. A novel gene of HIV-1, vpu, and its 16-kilodalton product. , 1988, Science.
[220] R. Perlmutter,et al. Lymphocyte activation provokes modification of a lymphocyte-specific protein tyrosine kinase (p56lck). , 1989, Journal of immunology.
[221] L. Montagnier,et al. Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers , 1990, Journal of virology.
[222] F. Miedema,et al. Programmed death of T cells in HIV-1 infection. , 1992, Science.
[223] J. Mullins,et al. Identification of a putative receptor for subgroup A feline leukemia virus on feline T cells , 1992, Journal of virology.
[224] B. Crise,et al. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor , 1990, Journal of virology.
[225] R. Ricciardi,et al. Adenovirus type 12 E1A gene represses accumulation of MHC class I mRNAs at the level of transcription. , 1988, Virology.
[226] K. M. Hwang,et al. CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycle. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[227] G. Pavlakis,et al. Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs , 1992, Molecular and cellular biology.
[228] A. Lanzavecchia,et al. T cells can present antigens such as HIV gp120 targeted to their own surface molecules , 1988, Nature.
[229] M. Skinner,et al. Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4 , 1988, Journal of virology.
[230] Q. Sattentau,et al. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding , 1991, The Journal of experimental medicine.
[231] M. Hammarskjöld,et al. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization , 1992, Journal of virology.
[232] L. Lasky,et al. Model for intracellular folding of the human immunodeficiency virus type 1 gp120 , 1989, Journal of virology.
[233] H. Temin,et al. Cell killing by avian leukosis viruses , 1981, Journal of virology.
[234] P. Rabinovitch,et al. Signal transduction through cd4 receptors: stimulatory vs. inhibitory activity is regulated by cd4 proximity to the cd31t cell receptor , 1988, European journal of immunology.
[235] C. Janeway,et al. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal. , 1986, The Journal of molecular and cellular immunology : JMCI.
[236] M. F. White. The transport of cationic amino acids across the plasma membrane of mammalian cells. , 1985, Biochimica et biophysica acta.
[237] G. Orloff,et al. HIV-1 binding to CD4 T cells does not induce a Ca2+ influx or lead to activation of protein kinases. , 1991, AIDS research and human retroviruses.
[238] A. Rein. Interference grouping of murine leukemia viruses: a distinct receptor for the MCF-recombinant viruses in mouse cells. , 1982, Virology.
[239] V. Fadok,et al. Apoptosis and programmed cell death in immunity. , 1992, Annual review of immunology.
[240] H. Christensen. A retrovirus uses a cationic amino acid transporter as a cell surface receptor. , 2009, Nutrition reviews.
[241] R. Desrosiers,et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS , 1991, Cell.
[242] H. Robinson,et al. Avian leukosis virus-induced osteopetrosis is associated with the persistent synthesis of viral DNA. , 1985, Virology.
[243] E. Hunter,et al. Oligomeric structure of a prototype retrovirus glycoprotein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[244] Luc Montagnier,et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV , 1984, Nature.
[245] B. Cullen,et al. The simian immunodeficiency virus Nef protein promotes degradation of CD4 in human T cells. , 1994, The Journal of biological chemistry.
[246] Q. Sattentau,et al. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. , 1990, Science.
[247] H. Robinson,et al. Accumulation of human immunodeficiency virus type 1 DNA in T cells: results of multiple infection events , 1990, Journal of virology.
[248] W. Blattner,et al. Cell surface antigens and function of monocytes and a monocyte-like cell line before and after infection with HIV. , 1990, Clinical immunology and immunopathology.
[249] E. Fenyö,et al. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs , 1990, Journal of virology.
[250] Ackrill Am,et al. Regulation of major histocompatibility class I gene expression at the level of transcription in highly oncogenic adenovirus transformed rat cells. , 1988 .
[251] Q. Sattentau,et al. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding , 1993, Journal of virology.
[252] H. Ostergaard,et al. Coclustering CD45 with CD4 or CD8 alters the phosphorylation and kinase activity of p56lck , 1990, The Journal of experimental medicine.
[253] N. Katunuma,et al. Involvement of tryptase‐related cellular protease(s) in human immunodeficiency virus type 1 infection , 1989, FEBS letters.
[254] M. Wainberg,et al. Association of p56lck with the cytoplasmic domain of CD4 modulates HIV‐1 expression. , 1994, The EMBO journal.
[255] K. M. Abraham,et al. Thymic tumorigenesis induced by overexpression of p56lck. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[256] Y. Koga,et al. Disturbance of nuclear transport of proteins in CD4+ cells expressing gp160 of human immunodeficiency virus , 1991, Journal of virology.
[257] Eric O Long,et al. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen , 1987, Nature.
[258] P. Earl,et al. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein , 1991, Journal of virology.
[259] J. Gabriel,et al. Proposed atomic structure of a truncated human immunodeficiency virus glycoprotein gp120 derived by molecular modeling: target CD4 recognition and docking mechanism. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[260] D. Hafler,et al. Phosphorylation of CD4 and CD8 molecules following T cell triggering. , 1987, Journal of immunology.
[261] J. Bolen,et al. Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activation , 1988, Molecular and cellular biology.
[262] G. Grunberger,et al. Tumor-promoting phorbol ester stimulates tyrosine phosphorylation in U-937 monocytes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[263] R. Willey,et al. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope , 1994, Journal of virology.
[264] Roland L. Dunbrack,et al. Phosphorylation-dependent down-modulation of CD4 requires a specific structure within the cytoplasmic domain of CD4. , 1991, The Journal of biological chemistry.
[265] A. Weiss,et al. CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. , 1993, The EMBO journal.
[266] Anthony S. Fauci,et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.
[267] T. Yoshimoto,et al. Identification of amino acid residues critical for infection with ecotropic murine leukemia retrovirus , 1993, Journal of virology.
[268] B. Malissen,et al. Role of L3T4 in antigen-driven activation of a class I-specific T cell hybridoma , 1985, The Journal of experimental medicine.
[269] Michael A. Bookman,et al. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56 lck , 1988, Cell.
[270] M. Eiden,et al. Glycosylation-dependent inactivation of the ecotropic murine leukemia virus receptor , 1994, Journal of virology.
[271] C. Griscelli,et al. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. , 1984, Science.
[272] J. Sodroski,et al. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. , 1987, Science.
[273] G. Schieven,et al. Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[274] R. Eddy,et al. Localization of the human gene allowing infection by gibbon ape leukemia virus to human chromosome region 2q11-q14 and to the homologous region on mouse chromosome 2 , 1991, Journal of virology.
[275] P. Sminia,et al. The replacement of monocytes and interleukin-1 by phorbol ester in lectin-induced proliferation of human thymocytes and T cells. , 1982, Immunobiology.
[276] J. Skowroński,et al. CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[277] B. Cullen,et al. Regulation of HIV‐1 gene expression , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[278] C. Auffray,et al. HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. , 1994, Journal of immunology.
[279] R. Weiss,et al. Receptor interference groups of 20 retroviruses plating on human cells. , 1990, Virology.
[280] C. Auffray,et al. Mutations in the D strand of the human CD4 V1 domain affect CD4 interactions with the human immunodeficiency virus envelope glycoprotein gp120 and HLA class II antigens similarly. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[281] N. Katunuma,et al. A novel membrane-bound serine esterase in human T4+ lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HIV-1. Purification and characterization. , 1990, The Journal of biological chemistry.
[282] J. Partanen,et al. The human p50csk tyrosine kinase phosphorylates p56lck at Tyr‐505 and down regulates its catalytic activity. , 1992, The EMBO journal.
[283] M. Baseler,et al. Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals , 1989, Journal of virology.
[284] B. Dutia,et al. Identification of a putative cellular receptor for the lentivirus visna virus. , 1991, The Journal of general virology.
[285] J. Sodroski,et al. Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein , 1992, Journal of virology.
[286] E. Freed,et al. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[287] G. Shaw,et al. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions , 1987, Journal of virology.
[288] R. Dewar,et al. Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport , 1989, Journal of virology.
[289] N. Raja,et al. Vpu-mediated proteolysis of gp160/CD4 chimeric envelope glycoproteins in the endoplasmic reticulum: requirement of both the anchor and cytoplasmic domains of CD4. , 1994, Virology.
[290] M. Martin,et al. Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[291] M. A. Jabbar,et al. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum , 1993, Journal of virology.
[292] M. Kieny,et al. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. , 1993, AIDS research and human retroviruses.
[293] C. Kneitz,et al. Mechanism of MHC class I downregulation in HIV infected cells. , 1992, Immunobiology.
[294] I. Roninson,et al. Isolation of dominant negative mutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments. , 1992, Nucleic Acids Research.
[295] T. Klimkait,et al. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release , 1990, Journal of virology.
[296] D. Stites,et al. HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes. , 1994, Journal of acquired immune deficiency syndromes.
[297] L. Montagnier,et al. Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo CD4 T cell depletion. , 1993, Seminars in immunology.
[298] J. Cunningham,et al. Transport of cationic amino acids by the mouse ecotropic retrovirus receptor , 1991, Nature.
[299] P. Kiener,et al. Physical associations between CD45 and CD4 or CD8 occur as late activation events in antigen receptor-stimulated human T cells. , 1991, Journal of immunology.
[300] Q. Sattentau,et al. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding , 1990, The Journal of experimental medicine.
[301] N. Hogg,et al. Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester. , 1987, Virology.
[302] K. Amrein,et al. The Src homology 2 domain of the protein-tyrosine kinase p56lck mediates both intermolecular and intramolecular interactions. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[303] M. Emerman,et al. Spleen necrosis virus, an avian immunosuppressive retrovirus, shares a receptor with the type D simian retroviruses , 1992, Journal of virology.
[304] E. Reinherz,et al. Human cytotoxic T cell clones directed at autologous virus-transformed targets: further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins. , 1983, Journal of immunology.
[305] S. M. Stearns,et al. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity , 1992, Journal of virology.
[306] R. Pal,et al. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[307] M. A. Gama Sosa,et al. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. , 1991, AIDS research and human retroviruses.
[308] J. Sodroski,et al. Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody , 1991, Journal of virology.
[309] B. Brooks,et al. Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein. , 1989, AIDS research and human retroviruses.
[310] J. Lifson,et al. Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion , 1986, The Journal of experimental medicine.
[311] A. F. Williams,et al. The immunoglobulin superfamily--domains for cell surface recognition. , 1988, Annual review of immunology.
[312] S. Shaw,et al. Evidence for the functional involvement of T cell differentiation antigens inT , 2003 .
[313] M. Hamaguchi,et al. A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1 , 1994, Journal of virology.
[314] G K Lewis,et al. Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop , 1993, Journal of virology.
[315] M P Dempsey,et al. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.
[316] D. Dormont,et al. Differential human immunodeficiency virus expression in CD4+ cloned lymphocytes: from viral latency to replication , 1992, Journal of virology.
[317] C. Janeway,et al. Coclustering of CD4 (L3T4) molecule with the T-cell receptor is induced by specific direct interaction of helper T cells and antigen-presenting cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[318] Y. Ron,et al. Reticuloendotheliosis type C and primate type D oncoretroviruses are members of the same receptor interference group , 1992, Journal of virology.
[319] A. Fischer,et al. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56Ick in human CD4 T lymphocytes , 1993, European journal of immunology.
[320] J. Bolen,et al. Alterations in tyrosine protein phosphorylation induced by antibody-mediated cross-linking of the CD4 receptor of T lymphocytes , 1989, Molecular and cellular biology.
[321] F. Alt,et al. Structure and expression of the human and mouse T4 genes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[322] J. Scheppler,et al. Down-modulation of MHC-I in a CD4+ T cell line, CEM-E5, after HIV-1 infection. , 1989, Journal of immunology.
[323] Dan R. Littman,et al. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4 , 1988, Nature.
[324] E. Freed,et al. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120 , 1994, Journal of virology.
[325] L. Ratner,et al. Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation , 1994, Journal of virology.
[326] Jerome H. Kim,et al. Consequences of human immunodeficiency virus type 1 superinfection of chronically infected cells. , 1993, AIDS research and human retroviruses.
[327] A. Douglas,et al. Specific structural alteration of the influenza haemagglutinin by amantadine. , 1990, The EMBO journal.
[328] W. Hunziker,et al. A di‐leucine motif mediates endocytosis and basolateral sorting of macrophage IgG Fc receptors in MDCK cells. , 1994, The EMBO journal.
[329] E. Reinherz,et al. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding , 1989, Nature.
[330] M. Stevenson,et al. HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.
[331] J. Hoxie,et al. Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus. , 1985, Science.
[332] J. Moore,et al. Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of a CD4 binding site. , 1992, AIDS research and human retroviruses.
[333] H. Sato,et al. Relationship between the cellular resistance to Friend murine leukemia virus infection and the expression of murine leukemia virus-gp70-related glycoprotein on cell surface of BALB/c-Fv-4wr mice. , 1986, Virology.
[334] J. Strominger,et al. Functional analysis of a cytoplasmic domain-deleted mutant of the CD4 molecule. , 1988, Journal of immunology.
[335] Michael E. Johnson,et al. Conformational rearrangements required of the V3 loop of HIV‐1 gp120 for proteolytic cleavage and infection , 1994, FEBS letters.
[336] P. Earl,et al. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity , 1988, Journal of virology.
[337] J. Bonifacino,et al. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[338] C. Kuiken,et al. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype , 1992, Journal of virology.
[339] E. Reinherz,et al. Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[340] U. Schubert,et al. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation , 1995, Journal of virology.
[341] E. Soeda,et al. Identification of sequences responsible for positive and negative regulation by E1A in the promoter of H‐2Kbm1 class I MHC gene. , 1990, The EMBO journal.
[342] S. Harrison,et al. Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[343] Y. Wang,et al. Erythropoietin receptor (EpoR)-dependent mitogenicity of spleen focus-forming virus correlates with viral pathogenicity and processing of env protein but not with formation of gp52-EpoR complexes in the endoplasmic reticulum , 1993, Journal of virology.
[344] C. Janeway,et al. Isoform‐specific associations of CD45 with accessory molecules in human T lymphocytes , 1992, European journal of immunology.
[345] T. Klimkait,et al. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein , 1989, Journal of virology.
[346] P. Luciw,et al. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. , 1989, Journal of immunology.
[347] J. Strominger,et al. Interaction between CD4 and class II MHC molecules mediates cell adhesion , 1987, Nature.
[348] J. J. Rosa,et al. CD4-binding regions of human immunodeficiency virus envelope glycoprotein gp120 defined by proteolytic digestion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[349] K. Strebel,et al. Sequences present in the cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to the human immunodeficiency virus type 1 Vpu protein , 1994, Journal of virology.
[350] H. Lane,et al. Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1. , 1992, Science.
[351] M. Emerman,et al. Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding , 1989, Journal of virology.
[352] G. Koretzky. Role of the CD45 tyrosine phosphatase in signal transduction in the immune system , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[353] H. Varmus,et al. Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses , 1993, Journal of virology.
[354] R. North,et al. Effects of ecotropic murine retroviruses on the dual-function cell surface receptor/basic amino acid transporter. , 1992, The Journal of biological chemistry.
[355] C. Kozak,et al. The mouse homolog of the Gibbon ape leukemia virus receptor: genetic mapping and a possible receptor function in rodents. , 1991, Virology.
[356] M. Ferrer,et al. Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation. , 1992, Journal of immunology.
[357] K. Nakamura,et al. Intracellular distribution of the envelope glycoprotein of human immunodeficiency virus and its role in the production of cytopathic effect in CD4+ and CD4- human cell lines , 1990, Journal of virology.
[358] M. Yuille,et al. HIV-1 infection abolishes CD4 biosynthesis but not CD4 mRNA. , 1988, Journal of acquired immune deficiency syndromes.
[359] T. Mosmann,et al. Functional diversity of T lymphocytes due to secretion of different cytokine patterns , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[360] C. Geisler,et al. CD3 gamma contains a phosphoserine‐dependent di‐leucine motif involved in down‐regulation of the T cell receptor. , 1994, The EMBO journal.
[361] H. Vinters,et al. High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients , 1990, Nature.
[362] J. Hoxie,et al. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. , 1986, Science.
[363] M. A. Jabbar,et al. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal. , 1993, The Journal of general virology.
[364] P. Earl,et al. Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain , 1990, Journal of virology.
[365] R. Mittler,et al. Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. , 1989, Science.
[366] J. Goudsmit,et al. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity , 1992, Journal of virology.
[367] J. Allison,et al. Altered expression of lymphocyte differentiation antigens on phorbol ester-activated CD4+8+ T cells. , 1988, Journal of immunology.
[368] J. Goudsmit,et al. Genomic diversity and antigenic variation of HIV‐1: links between pathogenesis, epidemiology and vaccine development , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[369] I. Weissman,et al. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus , 1988, Cell.
[370] G. Nabel,et al. An inducible transcription factor activates expression of human immunodeficiency virus in T cells , 1987, Nature.
[371] D. Littman,et al. The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits , 1992, The Journal of cell biology.
[372] J. Cunningham,et al. Genetic mapping of a cloned sequence responsible for susceptibility to ecotropic murine leukemia viruses , 1990, Journal of virology.
[373] C H Fox,et al. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. , 1989, Science.
[374] D. Klatzmann,et al. Characterization of the human CD4 gene promoter: transcription from the CD4 gene core promoter is tissue-specific and is activated by Ets proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[375] E. Fenouillet,et al. Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1 , 1990, Journal of virology.
[376] J. Margolick,et al. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. , 1987, Journal of immunology.
[377] H. Temin. Mechanisms of cell killing/cytopathic effects by nonhuman retroviruses. , 1988, Reviews of infectious diseases.
[378] J. Guardiola,et al. Identification of a CD4 binding site on the β2 domain of HLA-DR molecules , 1992, Nature.
[379] R. Garry,et al. A general model for the transmembrane proteins of HIV and other retroviruses. , 1989, AIDS research and human retroviruses.
[380] L. Werner,et al. Isolation and characterization of the neutralizable epitope of simian retrovirus-1 (SRV-1) and of the cell receptor for the virus. , 1991, Advances in experimental medicine and biology.
[381] T. Schulz,et al. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? , 1991, AIDS research and human retroviruses.
[382] H. Hoshino,et al. Isolation and characterization of human immunodeficiency virus type 1 variants infectious to brain-derived cells: detection of common point mutations in the V3 region of the env gene of the variants , 1994, Journal of virology.
[383] P. Earl,et al. Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers , 1992, Journal of Virology.
[384] K. Eichmann,et al. Biochemical evidence of the physical association of the majority of CD3 δ chains with the accessory/co‐receptor molecules CD4 and CD8 on nonactivated T lymphocytes , 1992, European journal of immunology.
[385] L. Mahan,et al. Characterization of a naturally occurring ecotropic receptor that does not facilitate entry of all ecotropic murine retroviruses , 1993, Journal of virology.
[386] W. Haseltine,et al. Disulfide bond formation in the human immunodeficiency virus type 1 Nef protein , 1993, Journal of virology.
[387] J. Sodroski,et al. Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region , 1992, Journal of virology.
[388] P. Anderson,et al. Comodulation of CD3 and CD4. Evidence for a specific association between CD4 and approximately 5% of the CD3:T cell receptor complexes on helper T lymphocytes. , 1988, Journal of immunology.
[389] J. Sodroski,et al. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. , 1985, Science.
[390] H. Moreau,et al. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells , 1992, Journal of virology.
[391] R. Axel,et al. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family , 1985, Cell.
[392] E K Ross,et al. Functional interaction of constant and variable domains of human immunodeficiency virus type 1 gp120 , 1989, Journal of virology.
[393] B. Gallis,et al. Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen. , 1986, The Journal of biological chemistry.
[394] J. Mullins,et al. Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses , 1993, Journal of virology.
[395] N. Katunuma,et al. Processing protease for gp160 human immunodeficiency virus type I envelope glycoprotein precursor in human T4+ lymphocytes. Purification and characterization. , 1993, The Journal of biological chemistry.
[396] D. Montefiori,et al. Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis. , 1987, AIDS research and human retroviruses.
[397] K. Robbins,et al. Isolation and oncogenic potential of a novel human src-like gene , 1986, Molecular and cellular biology.
[398] M. Greaves,et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.
[399] M. A. Jabbar,et al. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane , 1990, Journal of virology.
[400] B. Sleckman,et al. Glycolipid-anchored form of CD4 increases intercellular adhesion but is unable to enhance T cell activation. , 1991, Journal of immunology.
[401] J. Sodroski,et al. Functional role of human immunodeficiency virus type 1 vpu. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[402] E. Engleman,et al. CD4 molecules are associated with the antigen receptor complex on activated but not resting T cells. , 1988, Journal of immunology.
[403] Eric O Long,et al. Class II MHC molecules and the HIV gp 120 envelope protein interact with functionally distinct regions of the CD4 molecule. , 1989, The EMBO journal.
[404] J. J. Rosa,et al. Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region. , 1992, The EMBO journal.
[405] C. Janeway,et al. Physical association of CD4 and the T-cell receptor can be induced by anti-T-cell receptor antibodies. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[406] T. H. Lee,et al. Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120 , 1989, Journal of virology.
[407] J. Sodroski,et al. Identification of a protein encoded by the vpu gene of HIV-1 , 1988, Nature.
[408] J. Hilkens,et al. Identification of a cellular receptor for mouse mammary tumor virus and mapping of its gene to chromosome 16 , 1983, Journal of virology.
[409] M. Fournel,et al. Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk , 1993, Nature.
[410] Q. Sattentau,et al. A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. , 1991, The Journal of biological chemistry.
[411] A. Eb,et al. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells , 1983, Nature.
[412] D. Silberberg,et al. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. , 1991, Science.
[413] S. Pyle,et al. Lymphocyte activation by HIV-1 envelope glycoprotein , 1988, Nature.
[414] L. Lopalco,et al. Identification of human immunodeficiency virus type 1 glycoprotein gp120/gp41 interacting sites by the idiotypic mimicry of two monoclonal antibodies. , 1993, AIDS research and human retroviruses.
[415] I. Kawamura,et al. Depletion of the surface CD4 molecule by the envelope protein of human immunodeficiency virus expressed in a human CD4+ monocytoid cell line , 1989, Journal of virology.
[416] M. Marsh,et al. Phorbol ester-induced downregulation of CD4 is a multistep process involving dissociation from p56lck, increased association with clathrin- coated pits, and altered endosomal sorting , 1993, The Journal of experimental medicine.
[417] M. Newell,et al. T cell receptor aggregation, but not dimerization, induces increased cytosolic calcium concentrations and reveals a lack of stable association between CD4 and the T cell receptor. , 1992, Journal of immunology.
[418] P. Spear,et al. Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection , 1989, Journal of virology.
[419] D. Olive,et al. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry. , 1993, Journal of immunology.
[420] S. Harrison,et al. The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure , 1992, The Journal of experimental medicine.
[421] D R Burton,et al. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1 , 1994, Journal of virology.
[422] J. Minna,et al. Identification of mouse chromosomes required for murine leukemia virus replication , 1977, Cell.
[423] J. Lifson,et al. HIV interactions with CD4: a continuum of conformations and consequences. , 1992, Immunology today.
[424] E. Krebs,et al. A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA , 1985, Cell.
[425] J. Garcia,et al. Localization of the amphotropic murine leukemia virus receptor gene to the pericentromeric region of human chromosome 8 , 1991, Journal of virology.
[426] W. Haseltine,et al. Allelic variation in the effects of the nef gene on replication of human immunodeficiency virus type 1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[427] J. Coligan,et al. A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. , 1985, Science.
[428] D. Richman,et al. Rapid and reversible modulation of T4 (CD4) on monocytoid cells by phorbol myristate acetate: effect on HIV susceptibility. , 1988, Cellular immunology.
[429] A. Dalgleish,et al. New concepts in AIDS pathogenesis. , 1993, AIDS research and human retroviruses.
[430] M. Wainberg,et al. Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1 , 1991, Journal of virology.
[431] H. Lodish,et al. Oligomerization is essential for transport of vesicular stomatitis viral glycoprotein to the cell surface , 1986, Cell.
[432] M. Lenburg,et al. Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4 , 1993, Journal of virology.
[433] B. Margolin,et al. V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability , 1993, Journal of virology.
[434] S. Oliverio,et al. HIV‐1 gp120‐dependent induction of apoptosis in antigen‐specific human T cell clones is characterized by ‘tissue’ transglutaminase expression and prevented by cyclosporin A , 1994, FEBS letters.
[435] J. Justement,et al. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[436] H. Christensen,et al. The two-way flux of cationic amino acids across the plasma membrane of mammalian cells is largely explained by a single transport system. , 1982, The Journal of biological chemistry.
[437] R. Pisoni,et al. Important differences in cationic amino acid transport by lysosomal system c and system y+ of the human fibroblast. , 1987, The Journal of biological chemistry.
[438] T. Graf,et al. A plaque assay for avian RNA tumor viruses. , 1972, Virology.
[439] D. Baltimore,et al. Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. , 1989, Disease markers.
[440] D. Lamarre,et al. The MHC-binding and gp120-binding functions of CD4 are separable. , 1989, Science.
[441] Peter D. Kwong,et al. Crystal structure of an HIV-binding recombinant fragment of human CD4 , 1990, Nature.
[442] O. Danos,et al. Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. , 1994, Virology.
[443] M. Warmerdam,et al. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages , 1994, The Journal of experimental medicine.
[444] L. Chess,et al. Perturbation of the T4 molecule transmits a negative signal to T cells , 1985, The Journal of experimental medicine.
[445] W. Gallaher,et al. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus , 1987, Cell.
[446] F. Nappi,et al. A recombinant retrovirus carrying a non-producer human immunodeficiency virus (HIV) type 1 variant induces resistance to superinfecting HIV. , 1993, The Journal of general virology.
[447] B. Jameson,et al. Direct involvement of the CDR3-like domain of CD4 in T helper cell activation. , 1992, Journal of immunology.
[448] C. Broder,et al. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion , 1993, Journal of virology.
[449] Andreas Meyerhans,et al. Genetic organization of a chimpanzee lentivirus related to HIV-1 , 1990, Nature.
[450] G. Nabel,et al. Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection , 1991, Journal of virology.
[451] E. Hunter,et al. V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity. , 1992, Virology.
[452] M. Fresno,et al. CD4 gene transcription is transiently repressed during differentiation of myeloid cells to macrophage-like cells. , 1992, European journal of biochemistry.
[453] T. Yoshimoto,et al. Molecular cloning and characterization of a novel human gene homologous to the murine ecotropic retroviral receptor. , 1991, Virology.
[454] J. Sodroski,et al. Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein , 1991, Journal of virology.
[455] J. Schneider,et al. Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. , 1988, The Journal of biological chemistry.
[456] Edgar G. Engleman,et al. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane , 1987, Cell.
[457] H. Lyerly,et al. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. , 1989, Journal of immunology.
[458] J. Davide,et al. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. , 1990, Science.
[459] C. Janeway,et al. Evidence for a physical association of CD4 and the CD3: α : β T-cell receptor , 1987, Nature.
[460] E. Appella,et al. Expression of histocompatibility antigens H-2K, -D, and -L is reduced in adenovirus-12-transformed mouse cells and is restored by interferon gamma. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[461] M. Martin,et al. Association of human immunodeficiency virus type 1 envelope glycoprotein with particles depends on interactions between the third variable and conserved regions of gp120 , 1993, Journal of virology.
[462] C. Cheng‐Mayer,et al. Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. , 1989, Science.
[463] B. Cullen,et al. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. , 1991, Science.
[464] G. Griffiths,et al. Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells , 1991, The Journal of experimental medicine.
[465] L. Ratner,et al. Glucosidase inhibitors for treatment of HIV-1 infection. , 1992, AIDS research and human retroviruses.
[466] W. Biddison,et al. Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens , 1982, The Journal of experimental medicine.
[467] W. Blattner,et al. HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. , 1987, Journal of immunology.
[468] H. Ellens,et al. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[469] J. Moore,et al. A monoclonal antibody to the CDR-3 region of CD4 inhibits soluble CD4 binding to virions of human immunodeficiency virus type 1 , 1993, Journal of virology.
[470] M. Stevenson,et al. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products , 1990, Journal of virology.
[471] A. Burny,et al. Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor , 1993, Journal of virology.
[472] D. Richman,et al. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes , 1994, The Journal of experimental medicine.
[473] R. Weiss. Cellular Receptors and Viral Glycoproteins Involved in Retrovirus Entry , 1993 .
[474] H. Lyerly,et al. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[475] U. Koszinowski,et al. Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase , 1989, Cell.
[476] K. Amrein,et al. Ras GTPase-activating protein: a substrate and a potential binding protein of the protein-tyrosine kinase p56lck. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[477] J. Bonifacino,et al. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing. , 1991, Virology.
[478] J. Sodroski,et al. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding , 1990, Journal of virology.
[479] B. Roizman,et al. Glycoprotein D of herpes simplex virus encodes a domain which precludes penetration of cells expressing the glycoprotein by superinfecting herpes simplex virus , 1990, Journal of virology.